PT  - JOURNAL ARTICLE
AU  - Beuy Joob
AU  - Viroj Wiwanitkit
TI  - Evidence of Protective Effect of Hydroxychloroquine on COVID-19
AID  - 10.3899/jrheum.200638
DP  - 2020 May 25
TA  - The Journal of Rheumatology
PG  - jrheum.200638
4099  - http://www.jrheum.org/content/early/2020/06/09/jrheum.200638.short
4100  - http://www.jrheum.org/content/early/2020/06/09/jrheum.200638.full
AB  - We would like to share ideas on the report “Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials”1. Balevic noted that “well-designed clinical trials that include patients with rheumatic disease are urgently needed to characterize the efficacy, safety, and target exposures for hydroxychloroquine1.”